Figures computed from official regulatory filings — .
Analysttarget 10.8 USD (+215900%) · consensus 4.5/5 · 2 buy · 0 hold · 0 sell
Ownershipinsiders 3.76% · institutions 31.59% · short 8.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for STRATA Skin Sciences, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
226 buys56 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Rubinstein Samueltrack record | Sell | $7.3K | SEC | ||
| Rubinstein Samueltrack record |
| Buy |
| $4K |
| conv 67First in 12mo |
| SEC |
| Rubinstein Samueltrack record | Sell | $1.9K | SEC |
| Rubinstein Samueltrack record | Buy | $3K | conv 70First in 12mo | SEC |
| Rubinstein Samueltrack record | Sell | $9.6K | SEC |
| Gillings John T | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gov Shmuel | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rafaeli Dolev | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Allgeier Christina L | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Geiger Uri | Buy | $724K | conv 66ClusterFirst in 12mo | SEC |
| Rafaeli Dolev | Buy | $60K | conv 78ClusterFirst in 12mo | SEC |
| Accelmed Growth Partners (AGP) Ltd | Buy | $724K | conv 68ClusterFirst in 12mo | SEC |
| Gov Shmuel | Buy | $6.3K | conv 79First in 12mo | SEC |
| Gov Shmuel | Buy | $252.9 | conv 57First in 12mo | SEC |
| Gov Shmuel | Buy | $2.3K | conv 67First in 12mo | SEC |
| Gov Shmuel | Buy | $138 | conv 56First in 12mo | SEC |
| Gov Shmuel | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lesovitz Christopher | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rubinstein Samueltrack record | Sell | $320 | SEC |
| Rafaeli Dolev | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yaniv Irit | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Rubinstein Samueltrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cafran Wayne | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| 22NW GP, Inc.track record | Buy | $1M | conv 71ClusterFirst in 12mo | SEC |
| Moccia Robert Joseph | Buy | $28.1K | conv 73First in 12mo | SEC |